arrow
M

María Ángeles Vaz Salgado

Hospital Universitario Ramón y Cajal
H指数:14
被引数:1,146

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

VEGF信号通路生殖系多态性作为来自GEIS-33方案局部高级别骨肉瘤患者的预后药物基因组学生物标志物

2025-12-050
OAAI
PRIMARY RESULTS OF THE RANDOMIZED CLINICAL TRIAL OF BERUBICIN VS LOMUSTINE IN PATIENTS WITH GLIOBLASTOMA AFTER FAILURE OF PRIMARY THERAPY: DATA ANALYSIS AND FUTURE POSSIBILITIES

随机临床试验的初步结果:在初次治疗失败后的胶质母细胞瘤患者中比较鲁比西丁与洛莫司汀:数据分析与未来可能性

2025-11-010
OAAI
A PHASE 1 STUDY OF TINOSTAMUSTINE, A NOVEL ALKYLATING DEACETYLASE INHIBITOR, AS ADJUVANT TREATMENT IN NEWLY DIAGNOSED MGMT PROMOTER-UNMETHYLATED (UMGMT) GLIOBLASTOMA (GBM)

I期研究:评估替诺司他(tinostamustine,一种新型烷化去乙酰化酶抑制剂)作为新诊断的MGMT启动子未甲基化(UMGMT)胶质母细胞瘤(GBM)的辅助治疗方案。

2025-11-010
OAAI
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines

软组织肉瘤的诊断与治疗:西班牙肉瘤研究组(GEIS)指南

2025-09-290
OAAI
Antimicrobial Activity of Natural Extracts Against Catheter-Colonizing Methicillin-Resistant Staphylococcus aureus Clinical Isolates

天然提取物对导管定植耐甲氧西林金黄色葡萄球菌临床分离株的抗菌活性

2025-09-040
OA
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024-11-040
OAAI
P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY
2024-10-170
PRE
Early experience with azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial

阿泽利龙(azeliragon,一种RAGE抑制剂)与替莫唑胺和放疗联合用于新诊断胶质母细胞瘤患者的早期经验:CAN-201 NDG Ib/II期试验

2024-09-010
PRE
Progression-free survival 2 (PFS2) as a surrogate for overall survival in a multicentric real-world data cohort of glioblastoma (GBM)

无进展生存期2(PFS2)作为胶质母细胞瘤(GBM)多中心真实世界数据队列中总生存期的替代指标

2024-09-010
PRE
Survival outcomes of resected gastroesophageal cancer and impact of active surveillance: Experience from a tertiary centre
2024-06-010
PRE
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study
2024-05-172
OAAI